In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

In this week’s edition of InnovationRx, we look at how Daniel Nadler became a billionaire building a ChatGPT for doctors, big news from two Chinese biotech companies, what doctors think about AI and ...

Variational AI announced that it has been named Emerging Company of the Year - Biotech by Life Sciences BC. The recognition is part of the 27th Annual Life Sciences BC Awards, which celebrate ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...